CBLIF
Cobalamin binding intrinsic factor
Also known as: GIF, IF, IF_HUMAN, IFMH, INF, TCN3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27352
- Gene
- CBLIF
- Ensembl
- ENSG00000134812
- Chromosome
- 11
- Canonical length
- 417 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
417 residues, UniProt reviewed canonical sequence.
>P27352|CBLIF
1 MAWFALYLLS LLWATAGTST QTQSSCSVPS AQEPLVNGIQ VLMENSVTSS AYPNPSILIA
61 MNLAGAYNLK AQKLLTYQLM SSDNNDLTIG QLGLTIMALT SSCRDPGDKV SILQRQMENW
121 APSSPNAEAS AFYGPSLAIL ALCQKNSEAT LPIAVRFAKT LLANSSPFNV DTGAMATLAL
181 TCMYNKIPVG SEEGYRSLFG QVLKDIVEKI SMKIKDNGII GDIYSTGLAM QALSVTPEPS
241 KKEWNCKKTT DMILNEIKQG KFHNPMSIAQ ILPSLKGKTY LDVPQVTCSP DHEVQPTLPS
301 NPGPGPTSAS NITVIYTINN QLRGVELLFN ETINVSVKSG SVLLVVLEEA QRKNPMFKFE
361 TTMTSWGLVV SSINNIAENV NHKTYWQFLS GVTPLNEGVA DYIPFNHEHI TANFTQYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CBLIF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 1,485 nTPM
Expression across tissuesHPA
Tissue
- stomach: 1,485 nTPM
- duodenum: 0.5 nTPM
- lung: 0.5 nTPM
- cerebral cortex: 0.4 nTPM
- colon: 0.4 nTPM
- kidney: 0.4 nTPM
Single-cell type
- parietal cells: 6,426 nCPM
- gastric chief cells: 275 nCPM
- mucous neck cells: 31 nCPM
- retinal ganglion cells: 16 nCPM
- lacrimal acinar cells: 13 nCPM
- foveolar cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- cerebellum: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CBLIF.
Disease | AllUniProt
Conditions CBLIF is implicated in, by any mechanism.
- Hereditary intrinsic factor deficiency (IFD) MIM:261000
Disease | GeneticClinVar
15 pathogenic / likely-pathogenic of 175 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary intrinsic factor deficiency
- See cases
- Acute myeloid leukemia
Disease | AutoantibodyPubMed
Conditions in which antibodies against CBLIF are reported. Each links to that disease's full target list.
- Diabetes Mellitus, Type 1 9
- Thyroiditis, Autoimmune 5
- Anemia 4
- Polyendocrinopathies, Autoimmune 4
- Arthritis, Rheumatoid 3
- Celiac Disease 3
- Hyperthyroidism 3
- Hypothyroidism 3
Showing 8 of 17 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for CBLIF from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
166 publications
- Autoimmune atrophic gastritis--pathogenesis, pathology and management.
2013 · Nat Rev Gastroenterol Hepatol · RCR 11.2 · 305 citations - Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan.
2023 · J Gastroenterol · RCR 9.6 · 63 citations - Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency.
2009 · Am J Gastroenterol · RCR 4 · 131 citations - Diagnosis and classification of pernicious anemia.
2014 · Autoimmun Rev · RCR 4 · 99 citations - Increased prevalence of autoimmunity in Turner syndrome--influence of age.
2009 · Clin Exp Immunol · RCR 4 · 118 citations
Show 20 more of 166 total
- Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls.
1979 · Scand J Gastroenterol · RCR 4 · 78 citations - Prevalence of Autoimmune Gastritis in Individuals Undergoing Medical Checkups in Japan.
2019 · Intern Med · RCR 3.9 · 67 citations - Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women.
1978 · N Engl J Med · RCR 3.6 · 98 citations - Gender-sex differences in autoimmune atrophic gastritis.
2022 · Transl Res · RCR 3.1 · 32 citations - Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer.
2022 · JAMA Oncol · RCR 3.1 · 33 citations - Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis.
2022 · Sci Rep · RCR 3 · 29 citations - Vitamin B12 deficiency in untreated celiac disease.
2001 · Am J Gastroenterol · RCR 2.9 · 87 citations - Autoimmune Gastritis in Korean Patients with Gastric Tumors: Clinicopathologic Correlations and Diagnostic Histological Features.
2025 · Gut Liver · RCR 2.4 · 6 citations - Iron deficiency in pernicious anemia: Specific features of iron deficient patients and preliminary data on response to iron supplementation.
2024 · Clin Nutr · RCR 2.2 · 8 citations - Pepsinogens and other serum markers in pernicious anemia.
1988 · Am J Clin Pathol · RCR 2.2 · 42 citations - Daily intake of 4 to 7 microg dietary vitamin B-12 is associated with steady concentrations of vitamin B-12-related biomarkers in a healthy young population.
2010 · Am J Clin Nutr · RCR 2.2 · 56 citations - Pernicious anemia in blacks. A study of 64 patients from Washington, D. C., and Johannesburg, South Africa.
1981 · Am J Clin Pathol · RCR 2.2 · 39 citations - Atrophic Gastritis and Autoimmunity: Results from a Prospective, Multicenter Study.
2023 · Diagnostics (Basel) · RCR 1.8 · 11 citations - Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
2000 · Eur J Endocrinol · RCR 1.4 · 69 citations - Hidden gastric autoantibodies to intrinsic factor in pernicious anemia.
1970 · J Lab Clin Med · RCR 1.4 · 26 citations - Vitamin B12 (Cobalamin) Deficiency in Overt and Subclinical Primary Hypothyroidism.
2022 · Clin Med Insights Endocrinol Diabetes · RCR 1.4 · 11 citations - Diagnosis and management of pernicious anemia.
2011 · Curr Gastroenterol Rep · RCR 1.3 · 35 citations - Gastric lesion and pernicious anemia: a family study.
1978 · Acta Hepatogastroenterol (Stuttg) · RCR 1.3 · 21 citations - HL-A3 and HL-A7 in pernicious anaemia and autoimmune atrophic gastritis.
1975 · Clin Exp Immunol · RCR 1.2 · 26 citations - Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease.
2000 · Diabet Med · RCR 1.2 · 38 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CBLIF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CBLIF as an antibody target. Whether an autoantibody or antibody against CBLIF could matter depends on whether native CBLIF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CBLIF is annotated as secreted, so native CBLIF circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CBLIF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...